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Anyone who’s ever been in a jungle,
visited a zoo, or watched a talk-show
host grapple with a guest lemur
knows that there’s something unique
about primates that seems to capture
our imagination. Biologists find them
especially interesting, as inherent in
their human-like qualities is the
potential to tell us things we could
otherwise never know about
ourselves: where we came from, what
sets us apart as a species, and which
genetic idiosyncrasies make us
vulnerable to diseases. 
It’s now clear that genomic
approaches hold unprecedented
promise for shedding light on these
questions. But sequencing
mammalian genomes is still
expensive, with a price tag of roughly
$100 million for physical mapping,
sequencing and sequence assembly,
and the question of where to put
limited sequencing resources for
primates has been up for heated
discussion. In the time since two
letters appeared in Science last year
espousing cases for commitments to
sequence the chimp genome (Science
289:1295) and those of rhesus
macaque and baboon (Science
290:1504), the question of how to
allocate limited genomic resources to
studies of non-human primate
species has been the focus of a
visible and somewhat contentious
debate. There have yet to be formal
commitments, in the US or
elsewhere, to the whole-genome
sequencing of a non-human primate,
and while a main focus in the debate
has been on large-scale future
sequencing projects, many genomic
efforts are already under way, acting
to build a foundation for future
sequencing and provide new insights
ahead of complete sequence. 
The current trajectory for primate
sequencing in the US was set at the
Primate Genomics Workshop, a
meeting co-organized by the
Washington Regional Primate
Research Center (RPRC) and the
National Center for Research
Resources (NCRR) held in Seattle in
January. Chosen at this key meeting
as the first choice for a concerted
sequencing effort was the rhesus
macaque (Macaca mulatta), now the
front-runner for whole-genome
primate sequencing in the US. 
The question of how to allocate
limited genomic resources to
studies of non-human primate
species has been the focus of a
visible and somewhat contentious
debate
The subject of many years of
biomedical research on maladies
from AIDS to aging, the rhesus is
argued by proponents to be the most
valuable primate from a medical
standpoint, and moreover is a species
available in sufficient numbers and at
low enough cost to make in-depth
genetic and genomic analysis
feasible. 
For now, the priorities for rhesus
genomics are on developing the tools
of the trade: creating linkage maps,
BAC contigs and radiation hybrid
maps, all necessary ingredients to
make a solid case for a full-fledged
sequencing effort. Jeffrey Rogers of
the Southwest RPRC is heading up
work on a 10cM genetic linkage map
for the macaque, while Pieter de
Jong of the Children’s Hospital
Oakland Research Institute, a leader
in the development of BAC libraries
for the Human Genome Project, has
just completed a freely available
macaque BAC library boasting 12-
fold genomic coverage. And Leslie
Lyons and colleagues at the
California RPRC are in the midst of
banking DNA samples, establishing
macaque cell lines and creating
radiation hybrid maps. In addition
Lyons is seeking to develop genetic
screening tools that can eventually
facilitate the genetic management of
captive colonies and bring the power
of pedigree-based genetic analysis to
future macaque studies.
Another primate receiving
significant support for genomic
research is the baboon (Papio
hamadryas), which, like the rhesus,
has been the subject of extensive
biomedical research, serving as an
animal model for numerous human
afflictions including hypertension,
osteoporosis and diabetes. The
baboon has generally been seen as a
secondary candidate for near-term
full-genome sequencing, in part
because the species has been the
subject of somewhat more limited
study than the widely used rhesus
macaque. Baboons do, however, have
something the macaques don’t,
namely the distinction of having
many well-documented pedigrees,
some going back 25 years, according
to John VandeBerg of the Southwest
RPRC. Of all the work on non-
human primates, studies on the
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baboon have arguably come the
furthest in the development of
genomic resources, including a
genetic linkage map with about 350
markers and 7cM density. The map,
which was developed using primers
created for analyzing human
sequence, allows for full genome
scans to map phenotypes in
pedigreed individuals. Building on
the available tools for the baboon,
BAC contigs are in the process of
being assembled into a physical map. 
The chimpanzee (Pan troglodytes),
as our closest relative, is seen a third
key primate species for which
genomic information will be
particularly valuable. A chimp
sequence that could be compared to
our own (and others) would be a
treasure trove for anthropologists and
molecular biologists interested in
understanding primate evolution and
the basis for our own ‘humanness’.
Even without a full genome
sequence available, ambitious
evolutionary studies focusing on the
chimp genome are underway. In one
effort to gain a clearer view into our
still-murky hominid past, Svante
Paabo’s group at the Max Planck
Institute for Evolutionary
Anthropology in Leipzig has been
sequencing the chimp genome on a
superficial level — what Paabo calls
‘skimming’ — with the aim of
recognizing genetic signs of
evolutionary divergence from our
ancestors. Despite the extreme
similarity between the human and
chimpanzee genomes, there are
many diseases, including malaria,
asthma and numerous epithelial
cancers, to which chimps don’t
appear susceptible. Specific regions
of the chimp and human genomes
are being targeted in ongoing
comparative studies, among them
those of Ajit Varki who, with
colleagues at UC San Diego, is
pursuing evidence that subtle
differences in the glycobiology of
chimps and humans could underlie
our susceptibility to infectious
diseases such as flu and malaria.
At the moment, a chimpanzee
whole-genome sequencing initiative
in the US lacks the strong high-level
support enjoyed by a rhesus macaque
project, largely because the rhesus, as
a species more amenable to
biomedical experimentation, is seen
to hold more promise for medical
genomics. But for some time there
has been movement in Japan for a
large-scale chimp sequencing project,
and many chimp genomic resources,
including BAC libraries and BAC
end sequence, are being actively
developed there. According to
Yoshiyuki Sakaki of RIKEN and
Naruya Saitou of the National
Institute of Genetics, efforts to
sequence BAC clones will be
continuing through an emerging
international consortium that
includes groups from Japan, China,
Korea, Germany and Taiwan. 
Front runner: The rhesus macaque (Macaca
mulatta) looks like the first choice of primate
species for a US-led whole genome
sequencing project. This primate, found in the
wild from western Afgahanistan to northern
Thailand, has played a key role in biomedical
studies of maladies from AIDS to ageing. The
present priorities are to develop the key
genetic tools on which to build a full
sequencing program. Photograph: wild
rhesus macaques in northern India.
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